Health Care

U.S. stocks are rising Thursday as investors continue to snap up shares of companies that do better in times of faster economic growth, such as industrial and technology companies and banks.

Stocks that moved substantially or traded heavily Thursday: Cisco Systems Inc., up $1.99 to $44.08 The technology company had a solid second quarter and said it will buy back $25 billion in stock.

Insights from stem cell research find that it can be used to boost longevity and immunity.

Chicken salad sold at Fareway grocery stores in five Midwest states has been pulled from stores and consumers are advised to throw it away after it made people sick in Iowa.

The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval.

Warren Buffett's company is selling 35 million shares of its Phillips 66 stock back to the oil refiner for $3.3 billion.

Doctors would be able to scan cells for proteins that indicate bleeding and other neurological injuries after a blow to the head.

Businesses are fighting the Internal Revenue Service’s (IRS) decision to enforce ObamaCare’s employer mandate, which stipulates that companies with 50 or more employees must provide health care or pay a penalty.

Nektar will receive $1 billion in cash upfront and Bristol-Myers will purchase about 8.28 million Nektar shares at $102.60 per share, or an equity stake of just under 5 percent of the company

Actor James Naughton is raising money for a potential cure and encouraging people to get tested for pancreatic cancer, which claimed the life of his wife.

U.S. stocks are lower Tuesday morning as health care companies slump.

Some Medicare beneficiaries would face higher prescription drug costs under President Donald Trump's budget even as the sickest patients save thousands of dollars, a complex trade-off that may make it harder to sell Congress on the plan in an election year.

The latest on developments in financial markets (all times local): 9:35 a.m.

The Arizona senator’s thumbs down on the Senate floor last summer isn’t sitting well with the House speaker

The inventor of Narcan, Opiant Pharmaceuticals, plans to file with the Food and Drug Administration by 2020.

Amazon is reportedly focusing on a new aspect of its health care venture: medical supplies.

The report said groups who received the donations aligned themselves with industry goals and may have played a role in an epidemic that in 2016 led to 42,000 opioid overdose deaths.